Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial. uri icon

authors

  • Brown, Jacques P
  • Wang, Huei
  • Austin, Matthew
  • Wagman, Rachel B
  • Newmark, Richard
  • Libanati, Cesar
  • San Martin, Javier
  • Bone, Henry G
  • Prince, Richard L
  • Deal, Chad
  • Recker, Robert R
  • Douglas P. Kiel, MD, MPH
  • de Gregorio, Luiz H
  • Hadji, Peyman
  • Hofbauer, Lorenz C
  • Alvaro-Gracia, Jose M

publication date

  • January 2009